GlassScriptPhysician profile
Ahmed B Buksh
NPI 1457308736
$17,217.35
in general payments reported to CMS, 2019-2025
24 companies · $1,152 in 2025
The $1,152 reported for 2025 was more than what 82% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,770 · 2020: $2,618 · 2021: $3,759 · 2022: $2,269 · 2023: $1,966 · 2024: $1,685 · 2025: $1,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,802.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $5,227.03 | 2019-2022 | |
| Amniox Medical, INC. | $3,916.35 | 2019-2020 | |
| Axogen | $3,111.35 | 2019-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Biotissue Holdings INC. | $964.25 | 2021-2024 | |
| Smith+Nephew, INC. | $709.34 | 2019-2025 | Grafix, Stravix, Grafix Xc |
| Amgen INC. | $582.08 | 2024-2025 | Krystexxa |
| Horizon Therapeutics Plc | $475.87 | 2019-2023 | Krystexxa |
| Stryker Corporation | $414.33 | 2019-2025 | Infinity Adaptis, Actishield, Salvation |
| Trice Medical, INC. | $365.12 | 2022-2023 | |
| Nalu Medical, INC. | $272.11 | 2024-2025 | Nalu Neurostimulation System |
| Paratek Pharmaceuticals, INC. | $204.93 | 2023-2025 | Nuzyra |
| Bioventus LLC | $183.65 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Spr Therapeutics, INC | $146.04 | 2023 | Sprint Pns System |
| Wright Medical Technology, INC. | $138.92 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $124.99 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $99.68 | 2023 | Qutenza |
| Checkpoint Surgical, INC | $87.44 | 2022 | |
| Treace Medical Concepts, INC. | $67.05 | 2024 | |
| Organogenesis INC. | $27.72 | 2019 | |
| Kerecis Limited | $27.02 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Medtronic, INC. | $22.98 | 2022 | |
| Sandoz INC. | $18.13 | 2019 | |
| Depuy Synthes Sales INC. | $17.98 | 2025 | Motoband |
| Melinta Therapeutics, LLC | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Buksh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.